To test the efficacy of 3R and 4R full-length tau protein templates, Tennant et al. investigated tau seeding in a range of tauopathies (PiD, PSP, AD, FTLD) and observed optimal sensitivity and detection rates across diseases when they combining the two template proteins in equimolar ratios [79]. The gene discussed is MAPT; the disease is Alzheimer disease.